Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Composition : Glycopyrronium 25 mcg + Formoterol Fumarate 6 mcg
Dosage Form : Rota cap
Packaging Type :
Packaging :
Price : ₹1/-
Glycopryl F is a specialized inhalation medication designed for the effective management of chronic obstructive pulmonary disease (COPD). Each Rota Cap contains a precise combination of Glycopyrronium (25 mcg) and Formoterol Fumarate (6 mcg), which work synergistically to provide long-lasting relief from respiratory symptoms.
Glycopyrronium is an anticholinergic agent that helps to relax and open the airways by blocking the action of acetylcholine, a neurotransmitter that can cause bronchoconstriction. This action leads to improved airflow and reduced breathlessness. Formoterol Fumarate, a long-acting beta-agonist (LABA), complements this effect by stimulating beta-2 adrenergic receptors in the lungs, resulting in further bronchodilation. Together, these components help to alleviate symptoms such as wheezing, coughing, and shortness of breath, enhancing the quality of life for individuals with COPD.
Common side effects may include dry mouth, headache, dizziness, and palpitations. Some patients may experience throat irritation or cough. It is important to monitor for any unusual or severe reactions.
Glycopryl F is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults.
Glycopryl F should be used only as directed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms persist or worsen.
Composition : Formoterol (6mcg) + Budesonide (400mcg)
Composition : Formoterol (6mcg) + Budesonide (200mcg)
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
Composition : Salmeterol (50mcg) + Fluticasone Propionate (250mcg)
Composition : Salmeterol (25mcg) + Fluticasone Propionate (250mcg)
Composition : Doxofylline (400mg)
Composition : Doxofylline (400mg) + Montelukast (10mg)